Defensive antibacterial coating in orthopaedic surgery: Current evidence and future direction

Area of Science:

• Orthopaedic Surgery
• Biomaterials Science
• Infectious Diseases

Background:

• Periprosthetic joint infections (PJIs) are a major cause of morbidity and increased healthcare costs.
• Biofilm formation and bacterial adhesion are key mechanisms in PJIs.
• Novel strategies are needed to prevent and manage implant-related infections.

Purpose of the Study:

• To evaluate the efficacy of Defensive antibacterial coating (DAC®) hydrogel in preventing PJIs.
• To assess the impact of DAC® on infection recurrence in various orthopaedic procedures.
• To explore the potential of DAC® in reducing antibiotic use and hospital stays.

Main Methods:

• Review of early clinical evidence and data on DAC® hydrogel use.
• Analysis of DAC®'s mechanism of action, including bacterial adhesion reduction and antibiotic delivery.
• Assessment of DAC®'s compatibility with existing implants and surgical techniques.

Main Results:

• DAC® hydrogel demonstrates effectiveness in lowering infection recurrence in revision hip and knee arthroplasties.
• Additional benefits observed in trauma procedures and soft tissue repairs.
• DAC® is compatible with current implants and surgical protocols, potentially reducing antibiotic consumption and hospitalizations.

Conclusions:

• DAC® hydrogel is a promising strategy for combating PJIs and reducing infection recurrence.
• Further large-scale studies are needed, particularly for primary arthroplasty.
• DAC® has the potential to enhance patient outcomes and reduce the burden of implant-related infections.